| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CHX | Common Stock | Options Exercise | $178K | +36.2K | +7.34% | $4.92* | 529K | Jul 24, 2023 | Direct | |
| transaction | CHX | Common Stock | Sale | -$1.27M | -36.2K | -6.84% | $35.08 | 492K | Jul 24, 2023 | Direct | F1 |
| transaction | CHX | Common Stock | Sale | -$4.82M | -138K | -27.93% | $35.05 | 355K | Jul 24, 2023 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CHX | Stock Option (Right to Buy) | Options Exercise | $0 | -36.2K | -100% | $0.00* | 0 | Jul 24, 2023 | Common Stock | 36.2K | $4.92 | Direct |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | On July 24, 2023, pursuant to a Rule 10b5-1 trading plan adopted on February 24, 2023, the Reporting Person exercised options for 36,162 shares of ChampionX Corporation common stock and sold all 36,162 shares in multiple trades at prices ranging from $35.00 to $35.21, inclusive. The Reporting Person undertakes to provide, upon request, to the Securities and Exchange Commission staff, the Issuer or a security holder, full information regarding the number of shares and prices at which the transactions were effected. |
| F2 | These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 24, 2023. The shares were sold in multiple trades at prices ranging from $35.00 to $35.20, inclusive. The Reporting Person undertakes to provide, upon request, to the Securities and Exchange Commission staff, the Issuer or a security holder, full information regarding the number of shares and prices at which the transactions were effected. |
Chief Operating Officer and President, Chemical Technologies